European Economic
and Social Committee
Prevention of falsified medicinal products
Download — EESC opinion: Prevention of falsified medicinal products
Recommended for you
Medicinal products for human and investigational use / Derogations
Opinion
The EESC:welcomes this package of measures;recognises that need to pay particular attention to the situation of smaller EU Member States, Cyprus, Ireland and Malta in particula;stresses in particular…
Packaging and labelling of veterinary medicinal products – transitional rules
Opinion
Since the Committee endorses the content of the proposal and feels that it requires no comment on its part, it decided, at its 568th plenary session of 23 and 24 March 2022 (meeting of 23 March), to…
Securing Europe’s medicine supply: envisioning a Critical Medicines Act
Opinion
The Covid 19-pandemic has drawn attention to the role of the pharmaceutical industry and to production, availability and affordability of medicines and medicinal products on the European market…
Critical Medicines Act
Opinion
Key pointsThe EESC:recommends significantly increasing funding to support the objectives of the Critical Medicines Act. A dedicated European fund should be established for starting materials, Active…
Communication on availability of medicines
Opinion
On 24 October 2023 the European Commission adopted a set of actions to better prevent and mitigate critical medicine shortages in the EU. Recent critical shortages, including of certain antibiotics…